Healthy Weight Intervention Families During ALL Treatment: NOURISH-ALL

Launched by UNIVERSITY OF KANSAS MEDICAL CENTER · Sep 18, 2023

Keywords

ClinConnect Summary

The NOURISH-ALL trial is a study designed to help families of children with acute lymphoblastic leukemia (ALL) by providing support and resources during the early stages of treatment. This program includes six sessions aimed at improving family engagement and coping strategies. Over five years, the study will adapt and refine this intervention to ensure it meets the needs of families. The main goal is to see how well families participate in the program and to gather feedback on their experiences.

To be eligible for the study, children must be between 2 and 12 years old and have been diagnosed with ALL, having already completed the initial treatment phase. Their primary caregiver, who should be involved in the child's care, must be between 18 and 90 years old and able to communicate in English. The caregiver must also live with the child at least half of the time and agree to allow the child to participate. Participants can expect to engage in family sessions that focus on support and healthy habits, contributing to a better understanding of how families cope during this challenging time.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Children ages 2-12 years old and their primary caregiver ages 18-90
• • Child diagnosed with acute lymphoblastic leukemia (ALL)
• • Child completed induction phase of therapy and not yet in maintenance phase of therapy
• • Primary caregiver and child English language proficient
• • Primary caregiver able to provide permission for child to participate in research
• • Primary caregiver identifies as being involved with child's oncology care
• • Primary caregiver lives with child at least 50% of the time
• • Primary oncology provider confirms child is eligible to participate
• Exclusion Criteria:
• • Primary oncology provider identifies safety concerns regarding the child's participation in the study.